|
| |
| | | 52342 | | 21.10.1994 | | Advanz Pharma Specialty Medicine Switzerland GmbH | | 01.03.2004 | | | | | | | | | | | 05.02. | | | | 05.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Hytrin BPH 1 mg und 2 mg | Tabletten | Tablets (Terazosine 1 mg) + Tablets (Terazosine 2 mg) | G04CA03 | CI | | 02 | Hytrin BPH 2 mg | Tabletten | Tablets (Terazosine 2 mg) | G04CA03 | CI | | 03 | Hytrin BPH 5 mg | Tabletten | Tablets (Terazosine 5 mg) | G04CA03 | CI |
|
|
|
